Drug discontinuation: Caspofungin Acetate Injection (CASPOFUNGIN ACETATE)
FDA lists 3 presentations as To Be Discontinued. Companies: Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.), Fresenius Kabi USA, LLC.
- Published by source
- 2026-01-12
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
- Products
- Caspofungin Acetate Injection CASPOFUNGIN ACETATE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Marketed by Sandoz, Inc.; Discontinuation of the manufacture of the drug
- Discontinuation of the manufacture of the drug
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-01-12
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #1002 | new | 2026-10-22 | baefee148fc5…3a026d | 12378ace3134…27a11d |
Chain head: #1076 8ad5adc30b9b…88ce20